Despite intensive research, the molecular mechanisms of downstream ErbB receptor signaling and the effects on normal cell behavior and tumor progression remain ambiguous, and further detailed elucidation of ErbB-specific signaling mechanisms are essential to realizing novel diagnostic and prognostic markers and therapeutic targets. This evidence concerns the gene EGFR and neoplasm.